In the latest quarter, 12 analysts provided ratings for Comerica CMA, showcasing a mix of bullish and bearish perspectives.
The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 1 | 5 | 4 | 1 | 1 |
| Last 30D | 0 | 1 | 0 | 0 | 0 |
| 1M Ago | 0 | 1 | 0 | 0 | 0 |
| 2M Ago | 0 | 3 | 4 | 1 | 0 |
| 3M Ago | 1 | 0 | 0 | 0 | 1 |
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $72.58, a high estimate of $80.00, and a low estimate of $64.00. A 1.25% drop is evident in the current average compared to the previous average price target of $73.50.
Investigating Analyst Ratings: An Elaborate Study
A comprehensive examination of how financial experts perceive Comerica is derived from recent analyst actions. The following is a detailed summary of key analysts, their recent evaluations, and adjustments to ratings and price targets.
| Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
|---|---|---|---|---|---|
| Terry McEvoy | Stephens & Co. | Maintains | Overweight | $72.00 | $72.00 |
| David George | Baird | Raises | Outperform | $80.00 | $75.00 |
| Manan Gosalia | Morgan Stanley | Lowers | Equal-Weight | $71.00 | $76.00 |
| Karl Shepard | RBC Capital | Lowers | Outperform | $76.00 | $78.00 |
| Peter Winter | DA Davidson | Lowers | Neutral | $67.00 | $71.00 |
| Christopher Mcgratty | Keefe, Bruyette & Woods | Lowers | Outperform | $77.00 | $82.00 |
| David George | Baird | Lowers | Outperform | $75.00 | $80.00 |
| Ryan Nash | Goldman Sachs | Lowers | Neutral | $71.00 | $85.00 |
| Anthony Elian | JP Morgan | Lowers | Neutral | $70.00 | $73.00 |
| Jason Goldberg | Barclays | Raises | Underweight | $68.00 | $66.00 |
| Nicholas Holowko | UBS | Raises | Sell | $64.00 | $60.00 |
| David Rochester | Compass Point | Raises | Buy | $80.00 | $64.00 |
Key Insights:
- Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Comerica. This information offers a snapshot of how analysts perceive the current state of the company.
- Rating: Gaining insights, analysts provide qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Comerica compared to the broader market.
- Price Targets: Delving into movements, analysts provide estimates for the future value of Comerica's stock. This analysis reveals shifts in analysts' expectations over time.
To gain a panoramic view of Comerica's market performance, explore these analyst evaluations alongside essential financial indicators. Stay informed and make judicious decisions using our Ratings Table.
Stay up to date on Comerica analyst ratings.
About Comerica
With assets of around $80 billion, Comerica is primarily a relationship-based commercial bank headquartered in Dallas. In addition to Texas, Comerica's other primary geographies are California and Michigan, with locations also in Arizona and Florida and select businesses operating in several other states as well as Canada and Mexico.
Unraveling the Financial Story of Comerica
Market Capitalization Analysis: The company exhibits a lower market capitalization profile, positioning itself below industry averages. This suggests a smaller scale relative to peers.
Revenue Growth: Comerica displayed positive results in 3 months. As of 31 December, 2024, the company achieved a solid revenue growth rate of approximately 5.5%. This indicates a notable increase in the company's top-line earnings. As compared to its peers, the company achieved a growth rate higher than the average among peers in Financials sector.
Net Margin: Comerica's net margin is impressive, surpassing industry averages. With a net margin of 19.76%, the company demonstrates strong profitability and effective cost management.
Return on Equity (ROE): Comerica's ROE is below industry averages, indicating potential challenges in efficiently utilizing equity capital. With an ROE of 2.48%, the company may face hurdles in achieving optimal financial returns.
Return on Assets (ROA): Comerica's ROA falls below industry averages, indicating challenges in efficiently utilizing assets. With an ROA of 0.21%, the company may face hurdles in generating optimal returns from its assets.
Debt Management: Comerica's debt-to-equity ratio is below the industry average at 1.09, reflecting a lower dependency on debt financing and a more conservative financial approach.
The Basics of Analyst Ratings
Experts in banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their comprehensive research involves attending company conference calls and meetings, analyzing financial statements, and engaging with insiders to generate what are known as analyst ratings for stocks. Typically, analysts assess and rate each stock once per quarter.
Analysts may enhance their evaluations by incorporating forecasts for metrics like growth estimates, earnings, and revenue, delivering additional guidance to investors. It is vital to acknowledge that, although experts in stocks and sectors, analysts are human and express their opinions when providing insights.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. Click here to stay ahead of the market.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
